| Ingrediant | Function | Table A | Table B | Table C | Table D | ||
| A | Aceta- minophen | I | Drug | 300 mg | - | 300 mg | 300 mg |
| B | Aspirin | II | Drug | - | 300 mg | - | - |
| C | Lactose | III | Filler | 100 mg | 100 mg | - | 100 mg |
| D | Avicel | IV | Filler | - | - | 100 mg | - |
| starch | Dis-integrant | 50 mg | 50 mg | - | 50 mg | ||
| Avicel | Dis-integrant | - | - | 50 mg | - | ||
| Magsterate | Lubricant | 2 mg | 2 mg | 2 mg | 2 mg | ||
| Gelatin | Binder | 10 mg | 10 mg | 10 mg | 10 mg |
To determine which formulations are "pharmaceutically equivalent," we need to identify formulations with identical active ingredients in the same dosage form and quantity.
In the given table, the key components are:
Let's analyze each tablet:
To be pharmaceutically equivalent, formulations should have the same active ingredients at the same dose and dosage form. Let's find these:
Thus, the correct answer is that Tables A and C are pharmaceutically equivalent. This matches the correct answer provided: A and C.
List I | List II | ||
|---|---|---|---|
| A | Grignard reagent | I | R2CuLi |
| B | Gilman reagent | II | RMgX |
| C | Benzyne mechanism | III | 2 molecules of CH3CHO |
| D | Aldol condensation | IV | SNAr |
Choose the correct match of laxative and its Mechanism of Action (MOA):

Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing